Closing the Gap: Dr. Francesca Galbiati on Diagnosis, AI, and the Promise of Better Care

Today we welcome to our podcasts Dr. Francesca Galbiati who recently joined the California Center for Pituitary Disorders at UCSF, where she cares for patients with pituitary tumors, acromegaly, Cushing’s disease, and related hypothalamic conditions.

The Differential Diagnosis: Why thousands of pituitary patients wait a decade for a diagnosis, and what you can do to make a difference

From Lewis Blevins, MD, Neuroendocrinologist, Medical Director of the California Center for Pituitary Disorders, Professor of Neurological Surgery at UCSF and PWN cofounder – I’ve seen several patients recently who illustrate one of the basic,

The Cushing Syndrome Conundrum: Diagnosing and Managing a Silent Driver of Hypertension

In this recent Medscape InDiscussion podcast Dr. Marwah Abdalla welcomes PWN’s Dr. Lewis Blevins to talk about secondary hypertension. This episode focuses on Cushing syndrome, an often overlooked cause of secondary hypertension. We’ll discuss why

When your pituitary endocrinologist writes science fiction: introducing “2345”

When you visit Pituitary World News or Adrenal World News, you expect to find science and medical articles, patient-oriented books, podcasts and videos about pituitary and adrenal conditions, and expert opinions on current treatments, advocacy

From Discovery to Delivery: Crinetics Co-Founders on the Journey to Bring new drugs to Patients

In today’s podcast, Crinetics co-founders Dr. Scott Struthers and Dr. Steve Betz share their views and experiences in drug discovery and development, revealing what it really takes to bring a new medication from concept to patients.

Inside Camurus: Dr. Markus Johnsson talks about FluidCrystal® technology and next-generation treatment innovations

In the latest episode of the Pituitary World News podcast, Jorge D. Faccinetti sits down with Dr. Markus Johnsson, Senior VP of R&D at Camurus, to explore the fascinating world of FluidCrystal® technology. This innovative approach promises to revolutionize the way we think about drug delivery, providing long-lasting solutions for chronic diseases particularly for people with acromegaly.

Announcing Adrenal World News and new e-magazine for the adrenal world

FOR IMMEDIATE RELEASE: San Francisco – Friday, December 5, 2025 – Pituitary World News announced the launch of Adrenal World News, a new e-magazine dedicated to raising awareness of adrenal conditions which affect approximately 11 to 12 million people worldwide. Adrenal World News operates as a subsidiary of Pituitary World News

New 3-Month Octreotide Formulation Enters Phase 3 Testing for Acromegaly

In an important new development Swiss-based Debiopharm entered a Phase 3 trial of a new Octreotide formulation. The company is currently recruiting patients for the study. Debio 4126 is a sustained-release formulation designed to improve the convenience of somatostatin analogue​ (SSA) therapy for the treatment of acromegaly.